Environmental Protection Agency (EPA).
Notice of listening session.
EPA is announcing a listening session to be held on March 25, 2009, during the public comment period for the external review draft document entitled, “Toxicological Review of Halogenated Platinum Salts and Platinum Compounds: In Support of Summary Information on the Integrated Risk Information System (IRIS)”. This listening session is a new step in EPA's revised IRIS process, announced on April 10, 2008, for development of human health assessments for inclusion on IRIS. The purpose of the listening session is to allow all interested parties to present scientific and technical comments on draft IRIS health assessments to EPA and other interested parties during the public comment period and prior to the external peer review meeting. EPA welcomes the scientific and technical comments that will be provided to the Agency by the listening session participants. The comments will be considered by the Agency as it revises the draft assessment in response to the independent external peer review and public comments. All presentations will become part of the official and public record.
The EPA's draft assessment and peer review charge are available via the Internet on the National Center for Environmental Assessment's (NCEA) home page under the Recent Additions and the Data and Publications menus at http://www.epa.gov/ncea.
The listening session on the draft IRIS health assessment for Halogenated Platinum (Pt) Salts and Pt Compounds will be held on March 25, 2009, beginning at 9 a.m. and ending at 4 p.m., Eastern Daylight Time. If you wish to make a presentation at the listening session, you should register by March 18, 2009, and indicate that you wish to make oral comments at the session, and indicate the length of your presentation. At the time of your registration, please indicate if you require audio-visual aid (e.g., lap top and slide projector). In general, each presentation should be no more than 30 minutes. If, however, there are more requests for presentations than the allotted time will allow, then the time limit for each presentation will be adjusted accordingly. A copy of the agenda for the listening session will be available at the meeting. If no speakers have registered by March 18, 2009, the listening session will be cancelled. EPA will notify those registered to attend of the cancellation.
The public comment period for review of this draft assessment was announced previously in the Federal Register (FR) (74 FR 6154) on February 05, 2009. As stated in that FR notice, the public comment period began on February 5, 2009, and ends April 6, 2009. Any technical comments submitted during the public comment period should be in writing and must be received by EPA by April 6, 2009, according to the procedures outlined below. Only those public comments submitted using the procedures identified in the February 5, 2009, FR notice by the April 6, 2009, deadline will be provided to the independent peer-review panel prior to the peer-review meeting. The date and logistics for the peer-review meeting will be announced later in a separate FR notice.
Listening session participants who wish to have their comments available to the external peer reviewers should also submit written comments during the public comment period using the detailed and established procedures included in the aforementioned FR notice (February 5, 2009). Comments submitted to the docket prior to the end of the public comment period will be submitted to the external peer reviewers and considered by EPA in the disposition of public comments. Comments received in the docket after the public comment period closes must still be submitted to the docket but will not be submitted to the external peer reviewers.
The listening session on the draft Halogenated Platinum Salts and Platinum Compounds assessment will be held at the EPA offices at Two Potomac Yard (North Building), 7th Floor, Room 7100, 2733 South Crystal Drive, Arlington, Virginia, 22202. To attend the listening session, register by March 18, 2009, via the Internet at https://www2.ergweb.com/projects/conferences/peerreview/register-platinum.htm. You may also register via e-mail at e-mail: firstname.lastname@example.org (subject line: Halogenated Platinum Salts and Platinum Compounds Listening Session), by phone: 781-674-7374 or toll free at 800-803-2833, or by faxing a registration request to 781-674-2906 (please reference the “Halogenated Platinum Salts and Platinum Compounds Listening Session” and include your name, title, affiliation, full address and contact information). Please note that to gain entrance to this EPA building to attend the meeting, attendees must have photo identification with them and must register at the guard's desk in the lobby. The guard will retain your photo identification and will provide you with a visitor's badge. At the guard's desk, attendees should give the name Christine Ross and the telephone number, 703-347-8592, to the guard on duty. The guard will contact Ms. Ross who will meet you in the reception area to escort you to the meeting room. Upon your exit from the building please return your visitor's badge and you will receive the photo identification that you provided.
A teleconference line will also be available for registered attendees/speakers. The teleconference number is 866-299-3188 and the access code is 7033478503, followed by the pound sign (#). The teleconference line will be activated at 8:45 a.m., and you will be asked to identify yourself and your affiliation at the beginning of the call.
Information on Services for Individuals with Disabilities: EPA welcomes the attendance of the public at the “Halogenated Platinum Salts and Compounds Listening Session” and will make every effort to accommodate persons with disabilities. For information on access or services for individuals with disabilities, please contact Christine Ross at 703-347-8592 or email@example.com. To request accommodation of a disability, please contact Ms. Ross, preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For information on the public listening sessions, please contact Christine Ross, IRIS Staff, National Center for Environmental Assessment (NCEA), (8601P), U.S. EPA, 1200 Pennsylvania Avenue, NW., Washington, DC 20460; telephone: 703-347-8592; facsimile: Start Printed Page 10047703-347-8689; or e-mail: firstname.lastname@example.org. If you have questions about the draft Halogenated Platinum Salts and Platinum Compounds assessment, contact Andrew A. Rooney, IRIS Staff, National Center for Environmental Assessment, U.S. EPA, 109 T.W. Alexander Drive, B243-01, Durham, NC 27711; telephone: 919-541-1492; facsimile: 919-541-0245; or e-mail: email@example.com.End Further Info End Preamble Start Supplemental Information
This listening session is a new step in EPA's revised IRIS process, announced on April 10, 2008, for development of human health assessments for inclusion on IRIS. The new process is posted on the NCEA home page under the Recent Additions menu at http://www.epa.gov/ncea. Two listening sessions are scheduled under the new IRIS process. The first is during the public review of the draft assessment that includes only qualitative discussion. The second session is during the public review of the externally peer-reviewed draft assessment; if feasible, the completed draft of IRIS assessments will include both qualitative and quantitation elements. All IRIS assessments that are at the document development stage will follow the revised IRIS process, which includes the two listening sessions. However, when EPA initiated the new IRIS process, the draft assessment for Halogenated Platinum Salts and Platinum Compounds had already completed document development and been through several rounds of internal review. Therefore, EPA will only hold one listening session during the public review and comment period of the externally peer-reviewed draft.Start Signature
Dated: February 17, 2009.
Acting Director, National Center for Environmental Assessment.
[FR Doc. E9-4885 Filed 3-6-09; 8:45 am]
BILLING CODE 6560-50-P